73217-11-5Relevant articles and documents
Substituted indolyl and indazolyl derivatives and uses thereof
-
Page/Page column 24, (2010/02/17)
This application discloses compounds of generic Formula I: or pharmaceutically acceptable salts thereof, wherein A, R1, R2, R3, R4, Q, X, Y, m, p, and q are defined as described herein, useful for treatment of diseases associated with monoamine reuptake inhibitors. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the compounds.
Pharmaceutically efficacious pteridine derivatives
-
, (2008/06/13)
A pharmaceutically efficacious pteridine compound of formula I: STR1 wherein A denote a bridging hydrocarbon group containing 1 to 8 carbon atoms and containing a STR2 group directly bonded to the phenyl group and one of the methylene radicals of the bridging A group is optionally replaced by --O--; R1 is hydrogen, a cycloalkyl group with up to 7 carbon ring atoms, or an alkyl group having 1 to 6 carbon atoms, benzyl, or aryl; R2 is hydrogen or an alkyl group having 1 to 6 carbon atoms, or wherein R1 and R2 together form a five- or six-membered heterocyclic group which optionally contains additional hetero atoms selected from the group consisting of nitrogen, oxygen, and sulfur; R3 is hydrogen or an alkyl group having 1 to 3 carbon atoms; R3 ' is hydrogen, an optionally substituted alkyl group having 1 to 3 carbon atoms, carboxyl, hydroxyl or R3 and R3 ' together with the carbon atom to which they are attached form a cycloalkyl group and the pharmaceutically acceptable acid addition salts thereof.
